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Abstract: Orthopoxviruses (OPV) are emerging zoonotic pathogens, and an increasing number of
human infections is currently reported in Europe and in other continents, warranting heightened
attention on this topic. Following two OPV infections reported in veterinarians scratched by sick cats
in 2005 and 2007 in North-Eastern-Italy, involving a previously undescribed OPV, a similar strain
was isolated by a sick cat from the same territory in 2011, i.e., 6 years later, raising attention on OPV
circulation in this region. A surveillance program was launched to assess the OPV seroprevalence
among the veterinarians working in local veterinary clinics and in the local wild and domestic cat
population; seroprevalence was 33.3% in veterinarians and 19.5% in cats. Seroprevalence in cats was
unevenly distributed, peaking at 40% in the area where OPV-infected cats had been observed.
Keywords: Orthopoxvirus; seroprevalence; cat; veterinarian; Italy
1. Introduction
Orthopoxvirus (OPV) is a genus of the family Poxviridae, including multiple species isolated from
mammals, most of which are zoonotic viruses threatening human health. While naturally occurring
smallpox infections are indeed no longer a reason of concern (except in a bioterrorist context), after the
end of routine smallpox vaccination in 1977, an increased number of human infections with zoonotic
OPV such as Monkeypox virus or Cowpox virus (CPXV) [1–5] occurred, mainly affecting young
people [6]. Reports of OPV infections in animals and humans have largely increased during recent
decades, which has enhanced the perception of zoonotic potential of OPV and of increasing risk
for humans.
CPXV is the only known wildlife-borne OPV in Europe [7,8]; it is a zoonotic agent and is
considered the most common one [1]. Various animal species as well as humans are susceptible
to the infection [9–11]. Cases of transmission from pet rats to humans have been reported in northern
France [12] and in Germany [13–16] and these animals are emerging as a novel potential source of local
outbreaks of OPV zoonoses [17]. Small rodents are believed to be the current reservoir of CPXV [18],
whereas cats and cows are the most relevant source of transmission to humans [19] from 0.3% (Turkey)
up to 42.4% (Germany) [7,20–22]. Since the first report about a CPXV-infected domestic cat in Great
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Britain in 1977 [23], further cases have been documented in Europe [24,25]. Cats play a link between the
natural reservoirs and humans in the urban environment [1,25,26]. To date, at least five monophyletic
clades of CPXV have been identified, fulfilling the requirements to be considered as distinct viral
species [27,28]
Moreover, in both Great Britain and Germany CPXV infection of cats has been recognized as a
seasonal disease with a peak incidence in autumn [29]. In cats, the disease originates from exposure
to infected rodents; the clinical course varies from no symptoms to widespread skin necrotic lesions
and can ultimately lead to death [19]. Cutaneous clinical signs in infected cats include ulcerated,
erythematous and crusted lesions, predominantly on the head, neck and forelegs.
Despite the increased attention to this topic, there are only few studies on OPV seroprevalence in
European cats, ranging from 2% to 13.0% [24,30–33]; however, OPV seroprevalence in Italian cats has
not been addressed to date.
In the last decade, only three cases of OPV zoonotic cases were described in Italy, two of them
occurring in veterinary personnel scratched by sick domestic cats in 2005 and 2007. Although only
partial characterization of these OPV isolates was obtained, preliminary data supported that these
strains did not belong to known OPV species, and also indicated that OPV were circulating in local
fauna [25]. The third OPV zoonotic case was observed in the Lazio region during an OPV outbreak
that occurred in January 2015 in a colony of Macaca tonkeana (a species of primate in the family
of Cercopithecidae) in the province of Rieti [34], which caused a human asymptomatic infection [2].
In this case, the extended genomic characterization of the isolate (OPV Abatino) showed that it
may represent a novel clade of OPV, the nearest CPXV strain belonging to a novel CPXV lineage
(CPXV-Ger2010-MKY) [27], closely related to, although distinct from, the Ectromelia virus species
(ECTV). In addition, a virus very similar to the OPV Abatino has been recently isolated from a
fatal feline infection in Tuscany [26]. These novel OPV isolates, that may be the result of complex
evolution, indicate that previously reported cases in Italy could represent the tip of an iceberg yet to be
explored [35].
Taken together, the results of OPV surveillance in Italy show that the circulation of strains with
zoonotic potential may result from both local segregation and genetic evolution, and importation of
strains from other countries, leading to obsolescence the concept that the Alpes barrier historically
defended the Italian territories from OPV spread.
This paper describes the results of a surveillance program that was launched in 2011 among local
veterinary clinics of Friuli Venezia Giulia (FVG) to establish the OPV seroprevalence in veterinarians
and cats, as an indirect indicator of the extent of the circulation of these viruses in the human and
feline local populations.
2. Materials and Methods
2.1. Sample Collection
From May 2010 to October 2011, a total of 36 veterinarians and 226 cats (>1 year old), selected
from 11 veterinary clinics located in nine different areas of FVG territory, were included in the study.
Human and animal blood samples were sent to the Laboratory of Virology at the National Institute for
Infectious Disease “L. Spallanzani” in Rome, where serological investigation was performed.
A standardized questionnaire was used to record the past history, as well as to evaluate possible
risk factors of veterinaries and cats. Exposure rate of veterinarians was measured on the basis of
years of work experience and weekly exposure to cats. Individual written consent was obtained from
all participant veterinarians before applying the survey and drawing the blood samples. Individual
written consent was also obtained from the cat owners.
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2.2. Challenge Virus Stock Preparation
A Vaccinia virus (VACV, Lancy-Vaxina strain, Berna Biotech Ltd, Berna, Swiss) was propagated in
Vero E6 cells and harvested when 70% to 80% of the cell monolayer showed cytopathic effect (CPE).
After three cycles of freezing-thawing, cell lysates were clarified by low-speed centrifugation, aliquoted
and stored at –70 ◦C. The VACV virus stock used for all the experiments titered 107.8 plaque forming
units (PFU)/mL.
2.3. Serologic Tests
Serum samples from both cats and veterinarians were stored at –20 ◦C until use. The
presence of OPV-specific antibodies was assessed by immunofluorescence (IFA) and confirmed by
microneutralization (MNA) assay.
Slides for IFA were prepared in the laboratory, using Vero E6 cells infected with VACV. Specific
human IgG were detected using standard procedures [36]. In particular, rabbit anti-human IgG
conjugated with fluorescein isothiocyanate was used as a secondary antibody (Sigma-Aldrich, Inc.).
Negative and high-positive controls were included in each test. An IgG IFA titer ≥1:40 was scored
as positive.
MNA was performed according to a previously published method [37,38], using VACV for the
challenge. A serum from a previously (4 years) vaccinated subject was used as positive control.
An MNA titer ≥1:20 was scored as positive. Human samples positive to both IFA and MNA were
considered as true positive; cat serum samples were analyzed only by MNA.
2.4. Statistical Analysis
Chi square tests and Fisher exact tests were used as appropriate (Prism 5.0, Graphpad, California).
A p ≤ 0.05 was considered significant.
3. Results
In February 2011, a sick cat with skin lesions suggestive of OPV infection was observed at a
veterinary clinic located in Fagagna, FVG. The lesions, that had appeared one week before the visit,
healed about 10 days after the visit (Figure 1); overall, the disease course appeared to be mild, and the
cat recovered completely without sequelae.
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Figure 1. Clinical of the Orthopoxvirus (OPV)-infected cat. Skin lesions on the numerous vesicles 
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The OPV diagnosis was based on OPV-specific PCR [25]; partial sequence characterization of 
the virus isolate, based on complete hemagglutinin (HA, 948 nt) and crmB (1050 nt) genes, indicated 
that this virus was similar to OPV isolates obtained from veterinarians exposed to sick cats 4 and 6 
years before in the same geographical region [25], suggesting that OPV had been circulating in the 
region for years. 
This prompted us to initiate a seroprevalence study in veterinarians and cats of the region, to 
establish the extent of OPV circulation and the risk factors for persons professionally exposed to wild 
and domestic cats. 
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Figure 1. Clinical of the Orthopoxvirus (OPV)-infected cat. Skin lesions on the numerous vesicles spread
on the muzz e (a), head (b), back (c) and in the mammary rea (d) of the ick cat.
The OPV diagnosis was based on OPV-specific PCR [25]; partial sequence characterization of the
virus isolate, based on complete hemagglutinin (HA, 948 nt) and crmB (1050 nt) genes, indicated that
this virus was similar to OPV isolates obtained from veterinarians exposed to sick cats 4 and 6 years
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before in the same geographical region [25], suggesting that OPV had been circulating in the region
for years.
This prompted us to initiate a seroprevalence study in veterinarians and cats of the region, to
establish the extent of OPV circulation and the risk factors for persons professionally exposed to wild
and domestic cats.
The median age of the veterinarians was 41.5 years (range 25–57 years); 20 (55.6%) were female, 5
(13.8%) had underlying immunosuppression and 16 (44.4%) reported a previous smallpox vaccination.
The median clinic work experience was 15.5 years (range, 1–31 years); among veterinarians, 24 subjects
(66.7%) reported a weekly exposure to more than 10 cats and only nine (25%) subjects considered OPV
infection a professional risk. Eleven (30.5%) veterinarians reported prior exposure to more than 10 cats
presenting with ulcerative dermatitis.
The overall seroprevalence of OPV infection among veterinarians was 33.3% (12/36) with an
increasing trend according to age (Table 1); no significant association with exposure rate was observed.
Table 1. OPV-specific antibodies in veterinarians, Friuli Venezia Giulia (Northeastern Italy).
Veterinarians (Years) n Positive Prevalence (%) *
≤30 5 0 0
31–40 13 2 15.4
41–50 10 5 50
>50 8 5 62.5
* p = 0.0078, chi-squared test for trend.
A total of 24 veterinarians resulted OPV-seronegative, including four who were vaccinated; all the
remaining 12 seropositive veterinarians received previous smallpox vaccinations, but it is not possible
to establish whether the OPV-seropositivity could result from boosting antibody responses after OPV
exposure during the veterinary work.
In order to investigate the OPV seroprevalence in wild and domestic cats, 226 animals >1 year
old, referred by 11 selected veterinary clinics of FVG were sampled from February 2010 to May 2011.
The 226 cats analyzed had a median age of 6 (range 1–19 years); 134 cats (59.2%) were domestics and
108 (47.8%) lived in rural areas; 173 (76.5%) cats had been in contact with other cats while 163 (72.1%)
with rats. The overall OPV seroprevalence among cats was 19.5% (44/226), with a great variability
(ranging between 5% and 40%), depending on the area of residence (Table 2, Figure 2). The mean of
MNA positive titers was 42.35 with no significant differences among the residence areas of the animals.
Table 2. Seroprevalence of animals according to the residence area.
Area of Residence Positive/Analyzed Cats Seroprevalence
A (blue) 7/19 36.8%
B (red) 10/25 40%
C (turquoise) 11/72 15.3%
D (yellow) 1/8 12.5%
E (purple) 1/10 10%
F (pink) 2/40 5%
G (brown) 4/22 18.2%
H (green) 2/7 28.6%
I (grey) 1/3 33.3%
Not known 5/20 25%
Overall 44/226 19.5%
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San Daniele, Tarcento, Treppo Grande, Tricesimo; (C) Basiliano, Campoformido, Feletto Umberto, 
Grions del Torre, Martignacco, Pagnacco, Pasian di Prato, Passons, Povoletto, Remanzacco, 
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Corno di Rosazzo, Manzano, Pavia di Udine, San Giovanni al Natisone; (F) Carso, Gorizia, Trieste; 
(G) Camino al Tagliamento, Castions di Strada, Codroipo, Galleriano, Mortegliano, Pozzuolo del 
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No significantly different seroprevalence was observed in cats living in urban environments vs. 
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cats ere detected over 2005–2011. unicipalities included in the research areas ere the follo ing:
(A) Bordano, Cavazzo carnico, Gemona, Moggio, Osoppo, Resia, Tolmezzo, Treppo Carnico, Venzone;
(B) Buia, Cassacco, Colorendo di Montealbano, Fagagna, Majano, Ragogna, Rive d’Arcano, San
Daniele, Tarcento, Treppo Grande, Tricesimo; (C) Basiliano, Campoformido, Feletto Umberto, Grions
del Torre, Martignacco, Pagnacco, Pasian di Prato, Passons, Povoletto, Remanzacco, Tavagnacco,
Udine; (D) Cividale, Premariacco, San Leonardo, San Pietro al Natisone; (E) Buttrio, Corno di Rosazzo,
Manzano, Pavia di Udine, San Giovanni al Natisone; (F) Carso, Gorizia, Trieste; (G) Camino al
Tagliamento, Castions di Strada, Codroipo, Galleriano, Mortegliano, Pozzuolo del Friuli, Rivignano,
Talmassons; (H) Latisana, Muzzana, Palazzolo dello Stella, Portogruaro, Rivarotta di Teor, San Giorgio
di Nogaro; (I) Casarsa, Spilimbergo.
Seropositive cats were more frequent in the group of animals who had been in contact with other
cats (21.9% of cats with contacts were seropositive vs. 9.4% of cats without contacts, p ≤ 0.05).
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No significantly different seroprevalence was observed in cats living in urban environments vs.
cats living in rural environments, as well as in cats exposed or not exposed to rats. The seroprevalence
trend according to cat age was not significant.
4. Discussion
OPV with zoonotic potential are persistently circulating in FVG, and may represent a relevant
professional risk for persons exposed to animals. We launched a large seroepidemiological study, to
establish the OPV seroprevalence in cats and in veterinary clinic personnel from different areas of the
FVG region.
The overall seroprevalence in cats was 19.5%, and was higher than the prevalence observed in
previous studies in Europe (2% to 13.0%) [24,30–32]. Interestingly, a high geographic heterogeneity
was observed within the study region, with seroprevalence ranging from 5% and 40%; the highest
frequency was observed in the area where sick cats had been observed in the previous [25] and in the
present study. The only identified cat risk factor was having had contact with other cats.
The overall seroprevalence in veterinarians was 33.3%, with an increasing trend according to age,
while no significant association with exposure rate was observed. All veterinarians showing OPV
antibodies had received previous smallpox vaccinations (notably, four of the vaccinated persons did
not show detectable OPV antibodies), while none of the non-vaccinated veterinarians showed positive
OPV specific antibodies. Hence, increased age and previous smallpox vaccination appear to be the
main factors associated with the presence of OPV-specific antibodies. In other words, these findings
do not allow us to establish whether the antibody titer observed in the veterinarians represent an
anamnestic response to original vaccination favored by repeated work-related exposure, or merely
reflect humoral immune memory to vaccination.
The observations of this study might be alarming because OPV vaccination has been globally
discontinued since the late 1970s. This has resulted in reduction of protective immunity, not only
against smallpox virus, but also against a variety of other OPV over time, raising the chance of new
OPV cases in humans. OPV infection, although relatively rare in animals and uncommon in humans,
has gained some recognition through micro-outbreaks in recent years, and raised attention also due to
recently imported human cases of Monkeypox infections [3–5]. Moreover, OPV infection of humans is
not a notifiable disease in Italy, virological diagnosis relies on specialized laboratories, and is often
not included in the differential diagnosis. Increased public awareness and linkage between human
and veterinary health authorities is necessary to improve public health measures in the control of
zoonotic OPV.
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